TY - JOUR
T1 - Immunosuppression in Peripheral Neuropathy: Rationale and Reality
AU - Sutton, IJ
AU - Winer, John
PY - 2002/6/1
Y1 - 2002/6/1
N2 - Plasma exchange, intravenous immunoglobulin and corticosteroids continue to be the mainstay of treatment for inflammatory neuropathies. Recent trials demonstrate that combining these therapies is not significantly more effective than single agent treatment. The usefulness of novel immunotherapies and cytotoxic agents is difficult to ascertain because of the treatment of small numbers of patients in open-label studies.
AB - Plasma exchange, intravenous immunoglobulin and corticosteroids continue to be the mainstay of treatment for inflammatory neuropathies. Recent trials demonstrate that combining these therapies is not significantly more effective than single agent treatment. The usefulness of novel immunotherapies and cytotoxic agents is difficult to ascertain because of the treatment of small numbers of patients in open-label studies.
UR - http://www.scopus.com/inward/record.url?scp=0036605673&partnerID=8YFLogxK
U2 - 10.1016/S1471-4892(02)00158-3
DO - 10.1016/S1471-4892(02)00158-3
M3 - Article
C2 - 12020473
VL - 2
SP - 291
EP - 295
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 3
ER -